Lucid Diagnostics Inc. (NASDAQ:LUCD) Receives Average Rating of “Buy” from Analysts
Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Free Report) have been assigned a consensus rating of “Buy” from the five research firms that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
Shares of Lucid Diagnostics Inc. (NASDAQ:LUCD – Get Free Report) have been assigned a consensus rating of “Buy” from the five research firms that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]
